Menu

Blog

Archive for the ‘biotech/medical’ category: Page 199

Apr 1, 2024

More Complex Than Human Genome: Unlocking the Sweet Mysteries of Sugarcane DNA

Posted by in categories: biotech/medical, food, genetics

Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants. Exploring sugarcane’s genetic code could help researchers develop more resilient and productive crops, with implications for both sugar production and biofuels.

Apr 1, 2024

The Power of Vitamin D: From Osteoporosis to Cancer

Posted by in category: biotech/medical

Japanese researchers have uncovered the mechanism behind vitamin D’s bone-strengthening effects. Its potential impact on cancer is also becoming apparent. We explore the power of Vitamin D.

Apr 1, 2024

One Ring to Measure Blood-Glucose Level

Posted by in category: biotech/medical

A proposed ring-shaped device could measure the concentration of glucose in a person’s blood to an accuracy sufficient to make it clinically useful.

Apr 1, 2024

10 years on, a spin-off use for CRISPR: Infectious disease testing

Posted by in category: biotech/medical

The following is an interview with CRISPR co-discoverer and Nobel Prize-winner Dr. Jennifer Doudna.

Describe the “eureka moment” around CRISPR — the moment when you realized that this technology was not only possible but actually worked. How did you feel? Has your feeling changed since that eureka moment? If so, how?

There’s one moment that stands out in my mind, right at the time we realized what CRISPR could do and that we could “reprogram” it to edit specific sequences of DNA. I was cooking dinner and thinking about it, and I burst out laughing. My son was in the kitchen and he asked why I was laughing. So I explained it to him with a little drawing of a car zooming around, grabbing onto viruses, and chopping them up. I think my drawing did the trick, because he started laughing too.

Apr 1, 2024

ChatGPT can write medical notes faster without sacrificing quality

Posted by in categories: biotech/medical, robotics/AI

Cyrus Brodén, orthopedic physician and researcher at Uppsala University Hospital and Uppsala University.

Administrative tasks take up a large share of a doctor’s working hours, reducing the time for patient contact and contributing to a stressful work situation. Researchers at Uppsala University Hospital and Uppsala University, in collaboration with Danderyd Hospital and the University Hospital of Basel, Switzerland, have shown in a new study that the AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality.

Apr 1, 2024

OpenAI unveils voice-cloning tool

Posted by in categories: biotech/medical, robotics/AI

OpenAI on Friday revealed a voice-cloning tool it plans to keep tightly controlled until safeguards are in place to thwart audio fakes meant to dupe listeners.

A model called “Voice Engine” can essentially duplicate someone’s speech based on a 15-second audio sample, according to an OpenAI blog post sharing results of a small-scale test of the tool.

“We recognize that generating speech that resembles people’s voices has serious risks, which are especially top of mind in an election year,” the San Francisco-based company said.

Apr 1, 2024

Turning back the clock on aging immune systems: New treatment rejuvenates elderly defenses

Posted by in categories: biotech/medical, life extension

🧬🔬🐁


The effects of aging on the immune system

The aging immune system is associated with reduced lymphopoiesis, increased inflammation, and myeloid diseases due to alterations in self-renewing HSCs. During childhood, bal-HSCs predominate, thereby facilitating lymphopoiesis and adaptive immune responses.

Continue reading “Turning back the clock on aging immune systems: New treatment rejuvenates elderly defenses” »

Apr 1, 2024

New Alzheimer’s treatment slows disease with nanoparticles

Posted by in categories: biotech/medical, nanotechnology, neuroscience

Alzheimer’s is the most common form of dementia, affecting an estimated 6.7 million people in the US. Researchers seeking an effective treatment for the affliction have, over the last 30 years, focused their efforts on a protein known as amyloid beta (A-beta), which form clumps in the brain.

These clumps of A-beta proteins attack nerve cells, resulting initially in short-term memory impairment and later in the loss of judgment, language and thought processes.

Other researchers have previously developed an antibody which can identify and attach itself to A-beta proteins and delay the progression of Alzheimer’s in patients with early-to-mild cognitive impairment by up to 36%.

Apr 1, 2024

Mitochondrial DNA fragment losses predict Parkinson’s disease before symptoms appear

Posted by in categories: biotech/medical, neuroscience

The survival of neurons, unlike most other cells in the body, depends largely on the energy provided by mitochondria, intracellular organelles that contain their DNA to function properly.

Apr 1, 2024

Light-based bioprinting is illuminating the future of organ transplants

Posted by in categories: bioprinting, biotech/medical, life extension

Vidmantas Šakalys explains how laser technology is advancing bioprinting and opening up new possibilities in regenerative medicine.

Page 199 of 2,739First196197198199200201202203Last